POST Online Media Lite Edition



 

Herbalife expects EPS of $1.13 to $1.17

Staff writer |
Herbalife Ltd. rovided a preview of anticipated results for its fourth quarter and fiscal year ended December 31, 2013. Volume Points for full year and fourth quarter 2013 are expected to increase approximately 13.1% and 12.7%, respectively, compared to the prior year periods.

Article continues below






Net sales for full year and fourth quarter 2013 are expected to increase approximately 18.5% and 19.8%, respectively, compared to the prior year periods. Fourth quarter adjusted diluted EPS is expected to be in a range of $1.26 to $1.30.

Fourth quarter as reported diluted EPS is expected to be in a range of $1.13 to $1.17, as compared to prior year fourth quarter as reported diluted EPS of $1.00. There were no non-GAAP adjustments reported against the company's 2012 fourth quarter U.S. GAAP results.

Full year adjusted diluted EPS is expected to be in a range of $5.35 to $5.39. Full year as reported diluted EPS is expected to be in a range of $4.89 to $4.93, as compared to prior full year as reported diluted EPS of $3.94. There were no non-GAAP adjustments reported against the company's 2012 full year U.S. GAAP results.

The company expects to report full year financial results on February 18, 2014. The company's 2014 full year Volume Point growth and adjusted EPS guidance of 6.5% to 8.5% and $5.45 to $5.65, respectively, remains unchanged, despite approximately $0.10 adverse foreign currency exchange rate impact compared to prior guidance.

First quarter 2014 adjusted EPS is expected to be in a range of $1.24 to $1.28 despite an approximately $0.20 adverse foreign currency exchange rate impact compared to the prior year's results.

The company's board of directors has increased the existing share repurchase authorization to an available balance of $1.5 billion.3 The company's former share repurchase authorization of $1 billion had an available balance of $653 million. The company expects to begin repurchasing shares of Herbalife common stock.


What to read next

Herbalife Q1 net sales increased 1% to $1.1 billion
Herbalife Q3 sales went up 4%
Herbalife net sales increased 20 percent